Comparison of outcome between blood culture positive and negative infective endocarditis patients undergoing cardiac surgery.
Blood culture negative
Blood culture positive
Infective endocarditis
Intrahospital mortality
Long-term mortality
Procalcitonin
Journal
Journal of cardiothoracic surgery
ISSN: 1749-8090
Titre abrégé: J Cardiothorac Surg
Pays: England
ID NLM: 101265113
Informations de publication
Date de publication:
27 May 2021
27 May 2021
Historique:
received:
14
12
2020
accepted:
07
05
2021
entrez:
28
5
2021
pubmed:
29
5
2021
medline:
8
7
2021
Statut:
epublish
Résumé
Up to 30% or even more of all infective endocarditis (IE) cases are recognized as blood culture negative, meaning that the causative agent is left unidentified. The prompt diagnosis together with the identification of causative microorganism and targeted antibiotic treatment can significantly impact the prognosis of the disease and further patient's health status. In some studies, blood culture negative endocarditis has been shown to be associated with delayed diagnosis, worse outcome and course of the disease, and a greater number of intra and postoperative complications. We retrospectively analysed the medical records of all patients who underwent cardiac surgery for endocarditis between years 2016 and 2019. The aim of this study was to analyse short and long-term mortality and differences of laboratory, clinical and echocardiography parameters in patients with blood culture positive endocarditis (BCPE) and blood culture negative endocarditis (BCNE) and its possible impact on the clinical outcome. In our study population were 114 (55.1%) blood culture positive and 93 (44.9%) blood culture negative cases of infectious endocarditis. The most common pathogens in the blood culture positive IE group were S.aureus in 36 cases (31.6%), Streptococcus spp. in 27 (23.7%), E.faecalis in 24 (21.1%), and other microorganisms in 27 (23.7%). Embolic events were seen in 60 patients (28.9%). In univariate analyses, detection of microorganism, elevated levels of procalcitonin were found to be significantly associated with intrahospital death, however it did not reach statistical significance in multivariate analyses. Among microorganisms, S.aureus was significantly associated with intrahospital death in both univariate and multivariate analyses. There are no statistically significant differences between groups of BCPE and BCNE in terms of intrahospital mortality, hospital and ICU stay or 3-year mortality. There were higher levels of procalcitonin in BCPE group, however procalcitonin failed to show independent association with mortality in multivariate analysis. The most common microorganism in the BCPE group was S.aureus. It was associated with independently higher intrahospital mortality when compared to other causative microorganisms.
Sections du résumé
BACKGROUND
BACKGROUND
Up to 30% or even more of all infective endocarditis (IE) cases are recognized as blood culture negative, meaning that the causative agent is left unidentified. The prompt diagnosis together with the identification of causative microorganism and targeted antibiotic treatment can significantly impact the prognosis of the disease and further patient's health status. In some studies, blood culture negative endocarditis has been shown to be associated with delayed diagnosis, worse outcome and course of the disease, and a greater number of intra and postoperative complications.
METHODS
METHODS
We retrospectively analysed the medical records of all patients who underwent cardiac surgery for endocarditis between years 2016 and 2019. The aim of this study was to analyse short and long-term mortality and differences of laboratory, clinical and echocardiography parameters in patients with blood culture positive endocarditis (BCPE) and blood culture negative endocarditis (BCNE) and its possible impact on the clinical outcome.
RESULTS
RESULTS
In our study population were 114 (55.1%) blood culture positive and 93 (44.9%) blood culture negative cases of infectious endocarditis. The most common pathogens in the blood culture positive IE group were S.aureus in 36 cases (31.6%), Streptococcus spp. in 27 (23.7%), E.faecalis in 24 (21.1%), and other microorganisms in 27 (23.7%). Embolic events were seen in 60 patients (28.9%). In univariate analyses, detection of microorganism, elevated levels of procalcitonin were found to be significantly associated with intrahospital death, however it did not reach statistical significance in multivariate analyses. Among microorganisms, S.aureus was significantly associated with intrahospital death in both univariate and multivariate analyses.
CONCLUSIONS
CONCLUSIONS
There are no statistically significant differences between groups of BCPE and BCNE in terms of intrahospital mortality, hospital and ICU stay or 3-year mortality. There were higher levels of procalcitonin in BCPE group, however procalcitonin failed to show independent association with mortality in multivariate analysis. The most common microorganism in the BCPE group was S.aureus. It was associated with independently higher intrahospital mortality when compared to other causative microorganisms.
Identifiants
pubmed: 34044847
doi: 10.1186/s13019-021-01532-9
pii: 10.1186/s13019-021-01532-9
pmc: PMC8161995
doi:
Substances chimiques
Procalcitonin
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
147Références
Medicine (Baltimore). 2019 Nov;98(45):e17899
pubmed: 31702666
J Infect Chemother. 2012 Jun;18(3):318-23
pubmed: 22045162
Clin Infect Dis. 2003 Jul 15;37(2):167-72
pubmed: 12856207
J Cardiothorac Surg. 2017 Jul 20;12(1):57
pubmed: 28728556
Heart. 2006 Jan;92(1):124-30
pubmed: 16365367
J Am Coll Cardiol. 2015 Sep 1;66(9):1068-76
pubmed: 26314535
Ann Transl Med. 2020 May;8(9):610
pubmed: 32566636
Lancet. 2012 Mar 10;379(9819):965-975
pubmed: 22317840
BMC Med. 2011 Sep 22;9:107
pubmed: 21936959
Int J Infect Dis. 2020 Jul;96:25-30
pubmed: 32169690
Rev Esp Cardiol (Engl Ed). 2012 Oct;65(10):891-900
pubmed: 22771081
Clin Microbiol Infect. 2019 Oct;25(10):1226-1230
pubmed: 30616016
J Thorac Dis. 2020 Feb;12(Suppl 1):S5-S15
pubmed: 32148921
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
Crit Care. 2019 Dec 3;23(1):390
pubmed: 31796098
Crit Care. 2013 Sep 12;17(5):R202
pubmed: 24028771
JAMA. 2018 Jul 3;320(1):72-83
pubmed: 29971402
Clin Microbiol Rev. 2001 Jan;14(1):177-207
pubmed: 11148009
Surg Infect (Larchmt). 2013 Dec;14(6):489-511
pubmed: 24274059
Infection. 2016 Aug;44(4):459-66
pubmed: 26670038
Medicine (Baltimore). 2017 Nov;96(47):e8392
pubmed: 29381916
Indian Heart J. 2018 Dec;70 Suppl 3:S43-S49
pubmed: 30595302